Determination of aspirin and salicylic acid in transdermal perfusates

A high-performance liquid chromatographic (HPLC) method has been developed for the simultaneous determination of aspirin and salicylic acid in transdermal perfusates. The compounds were separated on a C 8 Nucleosil column (5 μm, 250×4.6 mm) using a mobile phase containing a mixture of water–acetonit...

Full description

Saved in:
Bibliographic Details
Published inJournal of chromatography. B, Biomedical sciences and applications Vol. 707; no. 1; pp. 322 - 327
Main Authors McMahon, Gillian P, O' Connor, Shane J, Fitzgerald, Desmond J, le Roy, Sylvie, Kelly, Mary T
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 10.04.1998
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A high-performance liquid chromatographic (HPLC) method has been developed for the simultaneous determination of aspirin and salicylic acid in transdermal perfusates. The compounds were separated on a C 8 Nucleosil column (5 μm, 250×4.6 mm) using a mobile phase containing a mixture of water–acetonitrile–orthophosphoric acid (650:350:2, v/v/v) and a flow-rate of 1 ml/min. The transdermal samples were in phosphate-buffered saline (PBS) and could be injected directly onto the HPLC system. The method was reproducible with inter-day R.S.D. values of no greater than 3.46 and 2.60% for aspirin and salicylic acid, respectively. The method was linear over the concentration range 0.2–5.0 μg/ml and had a limit of detection of 0.05 μg/ml for both compounds. For certain samples, it was necessary to ensure that no transmembrane leakage of the aspirin prodrugs had occurred. In these cases, a gradient was introduced by increasing the acetonitrile content of the mobile phase after the salicylic acid had eluted. The method has been applied to the determination of aspirin and salicylic acid in PBS following in vitro application of the compounds to mouse skin samples.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0378-4347
1387-2273
DOI:10.1016/S0378-4347(97)00580-X